Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06234384 · ClinicalTrials.gov registry record
Foundation for Sarcoidosis Research Advanced Cures Registry (FSR-SARC Registry)
A clinical trial of Sarcoidosis, sponsored by Foundation for Sarcoidosis Research.
- Recruiting
- Registry status
- 6,833
- Enrollment target
- 1
- Study location
NCT06234384: Recruiting study of Sarcoidosis, sponsored by Foundation for Sarcoidosis Research.
NCT06234384 is a study of Sarcoidosis that is actively recruiting participants, run by Foundation for Sarcoidosis Research. The registered enrollment target is 6,833 participants, above the 1,844-participant average among 21 other Sarcoidosis trials with a reported enrollment target (271% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06234384, a study of Sarcoidosis, is actively recruiting participants, sponsored by Foundation for Sarcoidosis Research.
- RECRUITING
- Registry status
- 6,833 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of the study is to create a longitudinal record of patient reported outcomes for people living with sarcoidosis that maintains privacy. Patients report on the following: demographics, disease symptoms, diagnostic journey, provider experience, disease treatment, and burden of disease. Patients can also link their Electronic Health Records (EHR). The goal is to create a natural history of sarcoidosis, support research, and better understand the needs of the sarcoidosis community.
Primary Outcome
Baseline survey completion
Conditions Studied
Interventions
- OTHER Sarcoidosis diagnosis
Study Locations (1)
Illinois
- Foundation For Sarcoidosis Research - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,833 participants |
| Start Date | 2013-07 |
| Est. Completion | 2033-07 |
What NCT06234384 shows while recruiting
NCT06234384 is an observational study that tracks outcomes without assigning an intervention. Its 6,833 participants enrollment target places it among the larger protocols in the corpus, above the 1,844-participant average among 21 other Sarcoidosis trials with a reported enrollment target (271% higher).
The record links to 1 condition, with Sarcoidosis appearing as the primary indexed condition, and to 1 intervention - of which Sarcoidosis diagnosis is the first listed.
NCT06234384 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06234384 about?
NCT06234384 is a clinical study titled "Foundation for Sarcoidosis Research Advanced Cures Registry (FSR-SARC Registry)". The goal of the study is to create a longitudinal record of patient reported outcomes for people living with sarcoidosis that maintains privacy. Patients report on the following: demographics, disease symptoms, diagnostic journey, provider experience, disease treatment, and burden of disease. Patien...
What is the current status of trial NCT06234384?
This trial is currently recruiting. The enrollment target is 6,833 participants. The study started on 2013-07. Estimated completion is 2033-07.
What conditions does trial NCT06234384 study?
This clinical trial studies the following conditions: Sarcoidosis.
What interventions are being tested in trial NCT06234384?
The interventions under investigation include: Sarcoidosis diagnosis (OTHER).
Who is sponsoring clinical trial NCT06234384?
This trial is sponsored by Foundation for Sarcoidosis Research, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06234384 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sarcoidosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06234384's enrollment target sits among peer trials
6,833 2nd of 21 the highest of 21 other Sarcoidosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sarcoidosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Quantification & Classification of Inflammatory Cells in Uveitis Using OCT
RECRUITING
-
Cardiovascular Multimodality Imaging Study
RECRUITING
-
Cardiac Sarcoidosis Randomized Trial
RECRUITING · Phase 3
-
Interstitial Lung Disease Research Unit Biobank
RECRUITING
-
Delayed-Enhancement Cardiovascular Magnetic Resonance in Patients With Sarcoidosis
RECRUITING
-
Vitamin D Homeostasis in Sarcoidosis
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03887715 · 6,800 participants · NA
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
- NCT05121324 · 6,700 participants · Phase 3
Pediatric Dose Optimization for Seizures in Emergency Medical Services
- NCT00260585 · 7,000 participants
Esophageal Cancer Risk Registry
- NCT04118660 · 7,000 participants
Thoracic Specimen Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia